EL7.AI
StocksMedium•19 November 2026•
3 min read

Medical Care Technologies Halts Share Issuance, Defers Review of Expansion and Funding Plans to 2027

Key Facts

1Medical Care Technologies suspended share issuance on November 19 and does not currently plan to resume it before 2027.
2Third-quarter net operating income rose 254% to $192,565, from $54,370 a year earlier.
3Third-quarter revenue was $538,981, compared with $478,128 in the corresponding period of 2025.
4The company recorded net income of $198,883 in the first nine months of 2026, after a net loss of $145,347 a year earlier.
5Private sales at Infinite Auctions exceeded $300,000 in the fourth quarter, according to the company.

Medical Care Technologies announced on November 19 that it had suspended share issuance and said it does not currently plan to resume it before 2027, when it will reassess its expansion and funding plans. The decision links the company’s financing policy to its operating results, after it recorded quarterly operating income far above the level a year earlier. The company said in its statement that it had "paused dilution and does not currently plan to resume share issuance until 2027." This means the timing of a review of the issuance is tied to an assessment of funding and expansion plans next year, rather than a specific announcement that issuance will resume. The company said the suspension decision could change depending on operating results, capital needs and other factors.

Third-quarter results for the period ended September 30, 2026, showed net operating income rising 254% to $192,565, from $54,370 in the year-earlier period. Gross profit also rose 55% to $240,839, compared with $155,720 a year earlier. Quarterly revenue was $538,981, up from $478,128 in the third quarter of 2025. In its filing with the U.S. Securities and Exchange Commission, the company linked the improvement in gross profit to a rebound in the sports collectibles market. The company announced its unaudited financial results on November 12, covering the three and nine months ended September 30.

The improvement extended to results for the first nine months of the year, when the company recorded net income of $198,883, compared with a net loss of $145,347 in the same period of 2025. Operating income for the period was $200,373, after an operating loss of $139,357 in the corresponding nine months of the prior year. These figures place the quarterly performance within a broader shift in the company’s results for the period, from losses in the first nine months of 2025 to profits in the corresponding period of 2026. The figures cover the period ended September 30, and the company announced the unaudited results on November 12. The year-over-year comparison provides context for the decision to suspend share issuance, while the company leaves its future funding needs under review.

Regarding current activity, the company said private sales at Infinite Auctions exceeded $300,000 in the fourth quarter. The company is also developing a paid external software agreement worth up to $250,000 for a web and enterprise platform to manage inventory and sales. It said the first payment under the agreement had begun, while technical development continues. The company places this work among its operating developments, which are taking place alongside the suspension of share issuance. As historical context, its filing with the SEC said Infinite Auctions had sold sports collectibles worth more than $13.5 million since 2016.

The announcement suspending issuance came after a preliminary prospectus filed by the company with the U.S. Securities and Exchange Commission on November 16 included an offering of up to 2,714,987,988 common shares, at a maximum price of $0.00012 per share. The prospectus provides a timeline for the company’s comments days later about halting share issuance, but does not change what it announced on November 19 about not currently planning to resume issuance before 2027. The financial statements attached to the company’s prospectus showed cash of $102,172 on September 30, 2026, compared with $77,946 on December 31, 2025. They also showed current liabilities of zero on September 30, compared with $26,679 at the end of 2025. The company said any decision to halt or resume share issuance could change depending on operating results, capital needs and other factors.

Open on chart